Effects of semaglutide on beta-cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial
Johansen NJ, Dejgaard TF, Lund A et al (2020) Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial
RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)
Arginine is a semi-essential amino acid that the body uses for multiple critical processes, including nitric oxide production, protein synthesis, and immune function
How do I cancel or reschedule my appointment
Keep L-Glutathione cartridges refrigerated for optimal potency